Ex-Jones Day boss: Healthcare venture capital is actually great, thank you very much
And don't expect family offices to take the place of venture capital.
Is venture capital bad for life sciences? 3 reasons why (and what should replace it)
Impact financing, venture philanthropy and a new breed of investors, says MIT's Andrew Lo.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.